Patents by Inventor Andrew T. Ulijasz

Andrew T. Ulijasz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9365623
    Abstract: Genetically-engineered cyanochrome fluorophore molecules (fluorophores) with increased fluorescence and with absorbing fluorescence in the blue and green (blue/green) portion of the light spectrum are provided. These fluorophores are derived from the domains of phytochromes, and in particular cyanobacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: June 14, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Andrew T. Ulijasz, Richard D. Vierstra
  • Patent number: 9296797
    Abstract: Genetically-engineered fluorophore molecules with increased fluorescence are provided. These fluorophores are derived from the domains of phytochromes, and in particular bacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: March 29, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Andrew T. Ulijasz, Junrui Zhang, Katrina T. Forest, David Anstrom, Jeremiah R. Wagner, Richard D. Vierstra
  • Publication number: 20150056646
    Abstract: Genetically-engineered cyanochrome fluorophore molecules (fluorophores) with increased fluorescence and with absorbing fluorescence in the blue and green (blue/green) portion of the light spectrum are provided. These fluorophores are derived from the domains of phytochromes, and in particular cyanobacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Application
    Filed: August 21, 2014
    Publication date: February 26, 2015
    Inventors: Andrew T. Ulijasz, Richard D. Vierstra
  • Patent number: 8822162
    Abstract: Genetically-engineered cyanochrome fluorophore molecules (fluorophores) with increased fluorescence and with absorbing fluorescence in the blue and green (blue/green) portion of the light spectrum are provided. These fluorophores are derived from the domains of phytochromes, and in particular cyanobacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: September 2, 2014
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Andrew T. Ulijasz, Richard D. Vierstra
  • Publication number: 20100303729
    Abstract: Genetically-engineered cyanochrome fluorophore molecules (fluorophores) with increased fluorescence and with absorbing fluorescence in the blue and green (blue/green) portion of the light spectrum are provided. These fluorophores are derived from the domains of phytochromes, and in particular cyanobacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Application
    Filed: May 27, 2010
    Publication date: December 2, 2010
    Inventors: Andrew T. Ulijasz, Richard D. Vierstra
  • Publication number: 20090061444
    Abstract: Genetically-engineered fluorophore molecules with increased fluorescence are provided. These fluorophores are derived from the domains of phytochromes, and in particular bacterial phytochromes. Methods for generating these fluorophores and various applications of these fluorophores are also provided.
    Type: Application
    Filed: July 2, 2008
    Publication date: March 5, 2009
    Inventors: Andrew T. Ulijasz, Junrui Zhang, Katrina T. Forest, David Anstrom, Jeremiah R. Wagner, Richard D. Vierstra
  • Patent number: 7067322
    Abstract: Disclosed are methods for making surface plasmon resonance-capable arrays wherein molecules, such as proteins or nucleic acids, or cells, are adhered to a metal substrate. The metal substrates are modified by depositing an ?-modified alkanethiol monolayer to the substrate and then contacting the ?-modified monolayer with a heterobifunctional linking compound. Biomolecules or cells can then be attached to the heterobifunctional linking compound. Also disclosed are arrays wherein glutathione-containing molecules are immobilized on the substrate and GST-containing molecules are then specifically immobilized onto the substrate, taking advantage of the affinity between glutathione and GST.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: June 27, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Robert M. Corn, Emily A. Smith, Bernard Weisblum, Matthew G. Erickson, Andrew T. Ulijasz, Matthew J. Wanat
  • Patent number: 6824994
    Abstract: Disclosed herein are methods for exposing a cell to a peptide so as to inhibit binding in a two-component signal transduction system. Such methods can control the development of antibiotic resistance in pathogenic bacteria and other hosts. Peptides useful in such methods, and methods for identifying such peptides, are also disclosed.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: November 30, 2004
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Bernard Weisblum, Andrew T. Ulijasz
  • Publication number: 20040033534
    Abstract: Disclosed herein are methods for exposing a cell to a peptide so as to inhibit binding in a two-component signal transduction system. Such methods can control the development of antibiotic resistance in pathogenic bacteria and other hosts. Peptides useful in such methods, and methods for identifying such peptides, are also disclosed.
    Type: Application
    Filed: August 2, 2002
    Publication date: February 19, 2004
    Inventors: Bernard Weisblum, Andrew T Ulijasz
  • Publication number: 20030100127
    Abstract: Disclosed are methods for making surface plasmon resonance-capable arrays wherein molecules, such as proteins or nucleic acids, or cells, are adhered to a metal substrate. The metal substrates are modified by depositing an &ohgr;-modified alkanethiol monolayer to the substrate and then contacting the &ohgr;-modified monolayer with a heterobifunctional linking compound. Biomolecules or cells can then be attached to the heterobifunctional linking compound. Also disclosed are arrays wherein glutathione-containing molecules are immobilized on the substrate and GST-containing molecules are then specifically immobilized onto the substrate, taking advantage of the affinity between glutathione and GST.
    Type: Application
    Filed: March 15, 2002
    Publication date: May 29, 2003
    Inventors: Robert M. Corn, Emily A. Smith, Bernard Weisblum, Matthew G. Erickson, Andrew T. Ulijasz, Matthew J. Wanat